Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Finance Industry Today.
Press releases published on December 8, 2025
December 8, 2025
FxScouts Announces Global Forex Broker Awards 2025
Indeterminate
EIN Presswire
December 8, 2025
AllScale Raises $5M Seed Led by YZi Labs to Build World's First Self-Custody Stablecoin Neobank
Indeterminate
EIN Presswire
December 8, 2025
AGII Launches Predictive Threshold Engine to Strengthen Data-Driven Blockchain Intelligence
Indeterminate
EIN Presswire
December 8, 2025
Colle AI (COLLE) Debuts Dynamic Media Sculptor for Next-Gen NFT Structural Design
Indeterminate
EIN Presswire
December 8, 2025
ExposeIQ Announces Its Medicare Fraud Defense Platform
Indeterminate
EIN Presswire
December 8, 2025
U.S. Investors Lead Locksley’s Oversubscribed A$17 Million Placement
Indeterminate
EIN Presswire
December 8, 2025
Dragon Slayers: Eat The Rich Becomes Bestseller as Debut Thriller Takes on Billionaires
Indeterminate
EIN Presswire
December 8, 2025
Bankaool partners with Maccorp to offer payments in 130 currencies
Indeterminate
EIN Presswire
December 8, 2025
AI Agents to Power 1,000% More Customer Interactions for Enterprises Globally by 2027
Indeterminate
GlobeNewswire
December 8, 2025
Initial admission to the Official List
Indeterminate
GlobeNewswire
December 8, 2025
SHELL PLC THIRD QUARTER 2025 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS
Indeterminate
GlobeNewswire
December 8, 2025
ING reports outcome of 2025 EU-wide transparency exercise
Indeterminate
GlobeNewswire
December 8, 2025
Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025
Indeterminate
GlobeNewswire
December 8, 2025
Galapagos presenteerde nieuwe ATALANTA-1 celtherapiedata in MCL op ASH 2025
Indeterminate
GlobeNewswire
December 8, 2025
OSE Immunotherapeutics Announces Strategic Amendment to AbbVie’s Partnership on ABBV-230 Development
Indeterminate
GlobeNewswire
December 8, 2025
OSE Immunotherapeutics annonce un amendement stratégique au partenariat avec AbbVie sur le développement d’ABBV-230
Indeterminate
GlobeNewswire
December 8, 2025
ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL
Indeterminate
GlobeNewswire